Diversified financial services company.
Biotech pricing issues Tick size pilot program, bio-tech investments, Jobs Act updates Biotech pricing
 ACA changes
MED - Medical/Disease Research/Clinical Labs FIN - Financial Institutions/Investments/Securities HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 88 - Securities & Exchange Commission (SEC) 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 88 - Securities & Exchange Commission (SEC) 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 88 - Securities & Exchange Commission (SEC) 1 - SENATE
DC STRATEGIES GROUP, LLC
1775 I Street, NW, Suite 1150, Washington, DC, 20006, US
ROY DELOACH MICHAEL D CHAPMAN ROY DELOACH MICHAEL D CHAPMAN ROY DELOACH MICHAEL D CHAPMAN